CLSD(Delisted)
Clearside Biomedical·NASDAQ
--
--(--)
Clearside Biomedical (CLSD) Financials Overview
Clearside Biomedical (CLSD) released its earnings on Aug 9, 2017: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Aug 9, 2017
EPS
Revenue
Revenue & Expenses
CLSD has released its 2025 Q3 earnings report, with revenue of 201.00K, reflecting a YoY change of -80.64%, and net profit of -5.97M, showing a YoY change of 22.32%. The Sankey diagram below clearly presents CLSD's revenue sources and cost distribution.
Key Indicators
Clearside Biomedical (CLSD) key financial stats and ratios, covering profitability, financial health, and leverage.
Clearside Biomedical (CLSD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Clearside Biomedical (CLSD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Clearside Biomedical (CLSD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Clearside Biomedical (CLSD) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Clearside Biomedical (CLSD) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
More Financial Metrics
You can ask Aime
No Data
